Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ARLTS1 and prostate cancer risk--analysis of expression and regulation.

PloS one - 1 Jan 2013

Siltanen Sanna, Fischer Daniel, Rantapero Tommi, Laitinen Virpi, Mpindi John Patrick, Kallioniemi Olli, Wahlfors Tiina, Schleutker Johanna

Abstract excerpt

Prostate cancer (PCa) is a heterogeneous trait for which several susceptibility loci have been implicated by genome-wide linkage and association studies. The genomic region 13q14 is frequently deleted in tumour tissues of both sporadic and familial PCa patients and is consequently recognised as a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to ADP-Ribosylation Factors
Share to Finland

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Genetic Association Studies

Share to Prostatic Neoplasms

Share to Quantitative Trait Loci

Source

Open in PubMed Open full text

Identifiers

PMID: 23940804
DOI: 10.1371/journal.pone.0072040
PMCID: PMC3734304

Genes

ARL11

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23940804-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ARLTS1 and prostate cancer risk--analysis of expression and regulation.PMID 23940804Read ↗

Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.Semantic proximity Read ↗

Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene.Semantic proximity Read ↗

The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness.Semantic proximity Read ↗

Familial Cancer Associated with a Polymorphism in<i>ARLTS1</i>Semantic proximity Read ↗

Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22Semantic proximity Read ↗

Prognostic role of genetic biomarkers in clinical progression of prostate cancer.Semantic proximity Read ↗

Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer.Semantic proximity Read ↗

FOXO1A Is a Candidate for the 13q14 Tumor Suppressor Gene Inhibiting Androgen Receptor Signaling in Prostate CancerSemantic proximity Read ↗

The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressivenessSemantic proximity Read ↗

Familial cancer associated with a polymorphism in ARLTS1.Semantic proximity Read ↗

Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.Semantic proximity Read ↗

Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.